Quick Answer
Inhibitor Therapeutics, Inc. reported Total Assets of $2.51 million for fiscal year 2025.
Inhibitor Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $2.51M | -55.9% |
| 2024 | $5.69M | -36.4% |
| 2023 | $8.95M | -25.3% |
| 2022 | $11.98M | +20271.4% |
| 2021 | $58.8K | -55.4% |
| 2020 | $131.8K | -85.4% |
| 2019 | $900.0K | -27.0% |
| 2018 | $1.23M | +60.5% |
| 2017 | $768.1K | -89.5% |
| 2016 | $7.34M | +728.4% |
| 2015 | $885.9K | +91.3% |
| 2014 | $463.0K | +4431.4% |
| 2013 | $10.2K | -98.9% |
| 2012 | $936.4K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.14M | -51.4% | -19.8% |
| June 30, 2025 | $3.91M | -45.5% | -13.3% |
| March 31, 2025 | $4.51M | -42.2% | -20.9% |
| December 31, 2024 | $5.69M | -36.4% | -11.7% |
| September 30, 2024 | $6.45M | -32.9% | -10.1% |
| June 30, 2024 | $7.17M | -29.4% | -8.0% |
| March 31, 2024 | $7.79M | -28.1% | -12.9% |
| December 31, 2023 | $8.95M | -25.3% | -6.9% |
- Inhibitor Therapeutics, Inc. showed a decrease of -55.9% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, Inhibitor Therapeutics, Inc.’s total assets has grown by 168.2% (from $936.4 thousand to $2.51 million).
- The most recent figure is from Inhibitor Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: